Discovery of novel mutations for clarithromycin resistance in Helicobacter pylori by using next-generation sequencing

Journal of Antimicrobial Chemotherapy

Volumn 69, Issue 7, 2014, Pages 1796-1803

  Binh, Tran Thanh ^a,b   Shiota, Seiji ^a   Suzuki, Rumiko ^a   Matsuda, Miyuki ^a   Trang, Tran Thi Huyen ^a   Kwon, Dong Hyeon ^c   Iwatani, Shun ^a,d   Yamaoka, Yoshio ^a,d  

^a OITA UNIVERSITY   (Japan)

^b CHO RAY HOSPITAL   (Viet Nam)

^c LONG ISLAND UNIVERSITY   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

23S rRNA; In vitro; InfB; Natural transformation; Rpl22

Indexed keywords

CLARITHROMYCIN; RNA 23S; ANTIINFECTIVE AGENT; BACTERIAL DNA; RIBOSOME DNA;

AGAR DILUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL GENOME; BACTERIAL MUTATION; BACTERIAL STRAIN; BACTERIUM TRANSFORMATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EPSILOMETER TEST; GENE MUTATION; HELICOBACTER PYLORI; HIGH THROUGHPUT SEQUENCING; INDEL MUTATION; INFB GENE; MINIMUM INHIBITORY CONCENTRATION; MUTATIONAL ANALYSIS; NEXT GENERATION SEQUENCING; NONHUMAN; RPL22 GENE; CHEMISTRY; CLUSTER ANALYSIS; DRUG EFFECTS; GENETIC SELECTION; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MOLECULAR GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; PHYLOGENY; VIRUS CULTURE;

ANTI-BACTERIAL AGENTS; CLARITHROMYCIN; CLUSTER ANALYSIS; DNA MUTATIONAL ANALYSIS; DNA, BACTERIAL; DNA, RIBOSOMAL; DRUG RESISTANCE, BACTERIAL; GENES, BACTERIAL; HELICOBACTER PYLORI; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MUTATION; PHYLOGENY; RNA, RIBOSOMAL, 23S; SELECTION, GENETIC; SERIAL PASSAGE; TRANSFORMATION, BACTERIAL;

EID: 84902440132     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dku050     Document Type: Article

References (59)

1. Peek RM Jr, Blaser MJ. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer 2002; 2: 28-37.
2. Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med 2002; 347: 1175-86.
3. Hosking SW, Chung SCS, Yung MY et al. Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial. Lancet 1994; 343: 508-10.
4. Takenaka R, Okada H, Kato J et al. Helicobacter pylori eradication reduced the incidence of gastric cancer, especially of the intestinal type. Aliment Pharmacol Ther 2007; 25: 805-12.
5. Malfertheiner P, Megraud F, O'Morain CA et al. Management of Helicobacter pylori infection-the Maastricht IV/Florence Consensus Report. Gut 2012; 61: 646-64.
6. Sugiyama T, Sakaki N, Kozawa H et al. Sensitivity of biopsy site in evaluating regression of gastric atrophy after Helicobacter pylori eradication treatment. Aliment Pharmacol Ther 2002; 16 Suppl 2: 187-90.
7. Vannella L, Lahner E, Bordi C et al. Reversal of atrophic body gastritis after H. pylori eradication at long-term follow-up. Dig Liver Dis 2011; 43: 295-9.
8. Selgrad M, Bornschein J, Malfertheiner P. Guidelines for treatment of Helicobacter pylori in the East and West. Expert Rev Anti Infect Ther 2011; 9: 581-8.
9. Fock KM, Katelaris P, Sugano K et al. Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection. J Gastroenterol Hepatol 2009; 24: 1587-600.
10. Chey WD, Wong BC, Practice Parameters Committee of the American Society of Gastroenterology. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol 2007; 102: 1808-25.
11. Jenks PJ. Causes of failure of eradication of Helicobacter pylori. BMJ 2002; 325: 3-4.
12. Mégraud F, Lamouliatte H. Review article: the treatment of refractory Helicobacter pylori infection. Aliment Pharmacol Ther 2003; 17: 1333-43.
13. Suzuki T, Matsuo K, Ito H et al. Smoking increases the treatment failure for Helicobacter pylori eradication. Am J Med 2006; 119: 217-24.
14. Vakil N, Megraud F. Eradication therapy for Helicobacter pylori. Gastroenterology 2007; 133: 985-1001.
15. Glupczynski Y, Mégraud F, Lopez-Brea M et al. European multicentre survey of in vitro antimicrobial resistance in Helicobacter pylori. Eur J Clin Microbiol Infect Dis 2001; 20: 820-3.
16. De Francesco V, Giorgio F, Hassan C et al. Worldwide H. pylori antibiotic resistance: a systematic review. J Gastrointestin Liver Dis 2010; 19: 409-14.
17. Mégraud F. H pylori antibiotic resistance: prevalence, importance, and advances in testing. Gut 2004; 53: 1374-84.
18. Francesco VD, Zullo A, Hassan C et al. Mechanisms of Helicobacter pylori antibiotic resistance: an updated appraisal. World J Gastrointest Pathophysiol 2011; 2: 35-41.
19. Mégraud F, Lehours P. Helicobacter pylori detection and antimicrobial susceptibility testing. Clin Microbiol Rev 2007; 20: 280-322.
20. Gerrits MM, van Vliet AH, Kuipers EJ et al. Helicobacter pylori and antimicrobial resistance: molecular mechanisms and clinical implications. Lancet Infect Dis 2006; 6: 699-709.
21. Versalovic J, Osato MS, Spakovsky K et al. Point mutations in the 23S rRNA gene of Helicobacter pylori associated with different levels of clarithromycin resistance. J Antimicrob Chemother 1997; 40: 283-6.
22. Burucoa C, Landron C, Garnier M et al. T2182C mutation is not associated with clarithromycin resistance in Helicobacter pylori. Antimicrob Agents Chemother 2005; 49: 868-70.
23. Rimbara E, Noguchi N, Kijima H et al. Mutations in the 23S rRNA gene of clarithromycin-resistant Helicobacter pylori from Japan. Int J Antimicrob Agents 2007; 30: 250-4.
24. Voelkerding KV, Dames SA, Durtschi JD. Next-generation sequencing: from basic research to diagnostics. Clinical Chemistry 2009; 55: 641-58.
25. Metzker ML. Sequencing technologies-the next generation. Nat Rev Genet 2010; 11: 31-46.
26. Lara-Ramírez EE, Segura-Cabrera A, Guo X et al. New implications on genomic adaptation derived from the Helicobacter pylori genome comparison. PLoS One 2011; 6: e17300.
27. Fischer W, Windhager L, Rohrer S et al. Strain-specific genes of Helicobacter pylori: genome evolution driven by a novel type IV secretion system and genomic island transfer. Nucleic Acids Res 2010; 38: 6089-101.
28. Avasthi TS, Devi SH, Taylor TD et al. Genomes of two chronological isolates (Helicobacter pylori 2017 and 2018) of the West African Helicobacter pylori strain 908 obtained from a single patient. J Bacteriol 2011; 193: 3385-6.
29. Devi SH, Taylor TD, Avasthi TS et al. Genome of Helicobacter pylori strain 908. J Bacteriol 2010; 192: 6488-9.
30. McClain MS, Shaffer CL, Israel DA et al. Genome sequence analysis of Helicobacter pylori strains associated with gastric ulceration and gastric cancer. BMC Genomics 2009; 10: 3.
31. Kawai M, Furuta Y, Yahara K et al. Evolution in an oncogenic bacterial species with extreme genome plasticity: Helicobacter pylori East Asian genomes. BMC Microbiol 2011; 11: 104.
32. Haas CE, Nix DE, Schentag JJ. In vitro selection of resistant Helicobacter pylori. Antimicrob Agents Chemother 1990; 34: 1637-41.
33. Aldana LP, Kato M, Kondo T et al. In vitro induction of resistance to metronidazole, and analysis of mutations in rdxA and frxA genes from Helicobacter pylori isolates. J Infect Chemother 2005; 11: 59-63.
34. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Seventeenth Informational Supplement M100-S17. CLSI, Wayne, PA, USA, 2007.
35. Ge Z, Taylor DE. H. pylori DNA Transformation by natural competence and electroporation. Methods Mol Med 1997; 8: 145-52.
36. Wang G, Taylor DE. Site-specific mutations in the 23S rRNA gene of Helicobacter pylori confer two types of resistance to macrolidelincosamide-streptogramin B antibiotics. Antimicrob Agents Chemother 1998; 42: 1952-8.
37. Wang Y, Roos KP, Taylor DE. Transformation of Helicobacter pylori by chromosomal metronidazole resistance and by a plasmid with a selectable chloramphenicol resistance marker. J Gen Microbiol 1993; 139: 2485-93.
38. Taylor DE, Ge Z, Purych D et al. Cloning and sequence analysis of two copies of a 23S rRNA gene from Helicobacter pylori and association of clarithromycin resistance with 23S rRNA mutations. Antimicrob Agents Chemother 1997; 41: 2621-8.
39. Ribeiro ML, Vitiello L, Miranda MC et al. Mutations in the 23S rRNA gene are associated with clarithromycin resistance in Helicobacter pylori isolates in Brazil. Ann Clin Microbiol Antimicrob 2003; 2: 11.
40. Sakinc T, Baars B, Wüppenhorst N et al. Influence of a 23S ribosomal RNA mutation in Helicobacter pylori strains on the in vitro synergistic effect of clarithromycin and amoxicillin. BMC Res Notes 2012; 5: 603.
41. Gerrits MM, de Zoete MR, Arents NL et al. 16S rRNA mutation-mediated tetracycline resistance in Helicobacter pylori. Antimicrob Agents Chemother 2002; 46: 2996-3000.
42. Kim JM, Kim JS, Kim N et al. Distribution of fluoroquinolone MICs in Helicobacter pylori strains from Korean patients. J Antimicrob Chemother 2005; 56: 965-7.
43. Moore RA, Beckthold B, Wong S et al. Nucleotide sequence of the gyrA gene and characterization of ciprofloxacin-resistant mutants of Helicobacter pylori. Antimicrob Agents Chemother 1995; 39: 107-11.
44. Kwon DH, Dore MP, Kim JJ et al. High-level b-lactam resistance associated with acquired multidrug resistance in Helicobacter pylori. Antimicrob Agents Chemother 2003; 47: 2169-78.
45. Gerrits MM, Schuijffel D, van Zwet AA et al. Alterations in penicillinbinding protein 1A confer resistance to b-lactam antibiotics in Helicobacter pylori. Antimicrob Agents Chemother 2002; 46: 2229-33.
46. Gregory ST, Dahlberg AE. Erythromycin resistance mutations in ribosomal proteins L22 and L4 perturb the higher order structure of 23 S ribosomal RNA. J Mol Biol 1999; 289: 827-34.
47. Davydova N, Streltsov V, Wilce M. et al. L22 ribosomal protein and effect of its mutation on ribosome resistance to erythromycin. J Mol Biol 2002; 322: 635-44.
48. Zaman S, Fitzpatrick M, Lindahl L et al. Novel mutations in ribosomal proteins L4 and L22 that confer erythromycin resistance in Escherichia coli. Mol Microbiol 2007; 66: 1039-50.
49. Roberts MC. Update on macrolide-lincosamide-streptogramin, ketolide, and oxazolidinone resistance genes. FEMS Microbiol Lett 2008; 282: 147-59.
50. Vester B, Douthwaite S. Macrolide resistance conferred by base substitutions in 23S rRNA. Antimicrob Agents Chemother 2001; 45: 1-12.
51. Nakajima Y. Mechanisms of bacterial resistance to macrolide antibiotics. J Infect Chemother 1999; 5: 61-74.
52. Weisblum B. Erythromycin resistance by ribosome modification. Antimicrob Agents Chemother 1995; 39: 577-85.
53. Gaynor M, Mankin AS. Macrolide antibiotics: binding site, mechanismof action, resistance. Curr Top Med Chem 2003; 3: 949-61.
54. Moore SD, Sauer RT. Revisiting the mechanism of macrolide-antibiotic resistance mediated by ribosomal protein L22. Proc Natl Acad Sci USA 2008; 105: 18261-6.
55. La Teana A, Gualerzi CO, Dahlberg AE. Initiation factor IF 2 binds to the alpha-sarcin loop and helix 89 of Escherichia coli 23S ribosomal RNA. RNA 2001; 7: 1173-9.
56. Tomb JF, White O, Kerlavage AR et al. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 1997; 388: 539-47.
57. Kutschke A, de Jonge BL. Compound efflux in Helicobacter pylori. Antimicrob Agents Chemother 2005; 49: 3009-10.
58. Hirata K, Suzuki H, Nishizawa T et al. Contribution of efflux pumps to clarithromycin resistance in Helicobacter pylori. J Gastroenterol Hepatol 2010; 25 Suppl 1: S75-9.
59. Alkan C, Sajjadian S, Eichler EE. Limitations of next-generation genome sequence assembly. Nat Methods 2011; 8: 61-5.